|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,860.00 JPY | -4.64% |
|
-4.60% | -27.31% |
| 04-03 | Transgene, NEC Bio Enter Partnership to Develop Cancer Vaccine | MT |
| 04-02 | Transgene and NEC Bio Sign License Agreement for TG4050 Development in Head and Neck Cancer | CI |
MarketScreener Strategies
Search
 | NEC's transformative move in US telecom | December 04, 2025 at 11:23 am |
No results for this search
- Stock Market
- Equities
- 6701 Stock
- News NEC Corporation
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition